RapX CMV is an investigational medicinal product consisting of donor-derived (allogeneic), naturally occurring, expanded CMV (cytomegalovirus)-specific T cells.

This product may offer an alternative for patients whose original stem cell donor is not available or is seronegative for cytomegalovirus as well as for patients with rare histocompatibility types.

RapX CMV is available in the UK upon request of a qualified physician under the ‘specials’ legislation.